(Q34021312)

30 July 2017

1 reference

title

Statin use and cancer risk: a comprehensive review (English)

1 reference

30 July 2017

Denise M Boudreau

1

1 reference

30 July 2017

Onchee Yu

series ordinal

2

1 reference

30 July 2017

Jeanene Johnson

series ordinal

3

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 July 2010

1 reference

Expert Opinion on Drug Safety

30 July 2017

published in

1 reference

30 July 2017

volume

9

1 reference

30 July 2017

issue

4

1 reference

30 July 2017

page(s)

603-621

1 reference

Statin drugs, serum cholesterol, and prostate-specific antigen in the National Health and Nutrition Examination Survey 2001-2004.

30 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2910322

Men presenting for radical prostatectomy on preoperative statin therapy have reduced serum prostate specific antigen

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2910322

Is statin use associated with prostate cancer aggressiveness?

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2910322

Prediagnostic total and high-density lipoprotein cholesterol and risk of cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2910322

Non-steroidal anti-inflammatory drugs and statins in relation to colorectal cancer risk

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2910322

Statins and the risk of colorectal carcinoma: a nested case-control study in veterans with diabetes

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2910322

Statin adherence and risk of accidents: a cautionary tale.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2910322

Statins and breast cancer: may matrix metalloproteinase be the missing link

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2910322

Statin use and female reproductive organ cancer risk in a large population-based setting

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2910322

Smoking and lung cancer: the role of inflammation

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2910322

Effect of statins on a wide range of health outcomes: a cohort study validated by comparison with randomized trials

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2910322

Cardiovascular medication use and risk for colorectal cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2910322

Chemoprevention of colorectal cancer: feasibility in everyday practice?

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2910322

Statins and cancer: A systematic review and meta-analysis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2910322

Statin use and risk of prostate cancer: results from a population-based epidemiologic study

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2910322

Combination regimen with statins and NSAIDs: a promising strategy for cancer chemoprevention

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2910322

Chronic statin therapy and the risk of colorectal cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2910322

Statin use and prostate cancer risk in a large population-based setting

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2910322

Statins and the risk of colorectal cancer: a meta-analysis of 18 studies involving more than 1.5 million patients

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2910322

Risk of colorectal cancer in patients prescribed statins, nonsteroidal anti-inflammatory drugs, and cyclooxygenase-2 inhibitors: nested case-control study

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2910322

Post-diagnosis statin use and breast cancer recurrence in a prospective cohort study of early stage breast cancer survivors

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2910322

Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studies

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2910322

Statins reduce the risk of lung cancer in humans: a large case-control study of US veterans

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2910322

Individual and joint use of statins and low-dose aspirin and risk of colorectal cancer: a population-based case-control study

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2910322

Statin use and breast cancer risk in a large population-based setting

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2910322

Risk of death associated with the use of conventional versus atypical antipsychotic drugs among elderly patients.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2910322

Statin use and the risk of 10 cancers.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2910322

Statin drugs and risk of advanced prostate cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2910322

Statins and risk of cancer: a systematic review and metaanalysis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2910322

Differential efficacy of 3-hydroxy-3-methylglutaryl CoA reductase inhibitors on the cell cycle of prostate cancer cells

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2910322

Breast cancer growth prevention by statins

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2910322

Statin use and breast cancer: prospective results from the Women's Health Initiative.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2910322

Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2910322

Statins and cancer risk: a meta-analysis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2910322

Statins and cancer prevention

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2910322

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2910322

Statins and cancer development.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2910322

Statins and prostate cancer risk: a case-control study

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2910322

Statins and the risk of colorectal cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2910322

The effect of statins on serum prostate specific antigen levels in a cohort of airline pilots: a preliminary report

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2910322

Cancer risk among statin users: a population-based cohort study

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2910322

Statin use and cancer risk in the General Practice Research Database

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2910322

Non-steroidal anti-inflammatory drugs and molecular carcinogenesis of colorectal carcinomas

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2910322

Statins can inhibit proliferation of human breast cancer cells in vitro

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2910322

The statins as anticancer agents

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2910322

Molecular mechanism of the anti-cancer activity of cerivastatin, an inhibitor of HMG-CoA reductase, on aggressive human breast cancer cells

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2910322

Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT).

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2910322

Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2910322

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2910322

Statin use, hyperlipidaemia, and the risk of breast cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2910322

HMG-CoA reductase inhibitors and the malignant cell: the statin family of drugs as triggers of tumor-specific apoptosis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2910322

Cerivastatin, an inhibitor of HMG-CoA reductase, inhibits the signaling pathways involved in the invasiveness and metastatic properties of highly invasive breast cancer cell lines: an in vitro study

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2910322

HMG-CoA reductase inhibitor mevastatin enhances the growth inhibitory effect of butyrate in the colorectal carcinoma cell line Caco-2

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2910322

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2910322

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2910322

Cholesterol lowering with statin drugs, risk of stroke, and total mortality. An overview of randomized trials

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2910322

Lovastatin-induced apoptosis in prostate stromal cells

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2910322

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2910322

Carcinogenicity of lipid-lowering drugs

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2910322

Assessing possible hazards of reducing serum cholesterol

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2910322

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2910322

Relationship between low cholesterol and disease. Evidence from epidemiological studies and preventive trials

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2910322

Serum cholesterol and cancer risk: an epidemiologic perspective

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2910322

Do statins cause cancer? A meta-analysis of large randomized clinical trials

5 July 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740331003662620

Statins, low-density lipoprotein cholesterol, and risk of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740331003662620

21 January 2018

Statins and cancer risk

1 reference

https://api.crossref.org/works/10.1517%2F14740331003662620

Statin use and the risk of breast and prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740331003662620

The association between 3-hydroxy-3-methylglutaryl conenzyme A inhibitor use and breast carcinoma risk among postmenopausal women: a case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740331003662620

Serum lipids, lipid-lowering drugs, and the risk of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740331003662620

Screening statins for possible carcinogenic risk: up to 9 years of follow-up of 361,859 recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740331003662620

Incidence of cancer and statin usage--record linkage study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740331003662620

Use of statins and breast cancer: a meta-analysis of seven randomized clinical trials and nine observational studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740331003662620

Statin use and risk of colorectal cancer in a cohort of middle-aged men in the US: a prospective cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740331003662620

The association between statins and cancer incidence in a veterans population

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740331003662620

Statins and cancer: a meta-analysis of case-control studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740331003662620

Statin use and risk of prostate cancer in the California Men's Health Study cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740331003662620

Cholesterol-lowering drugs and prostate cancer risk: a population-based case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740331003662620

Statins, especially atorvastatin, may favorably influence clinical presentation and biochemical progression-free survival after brachytherapy for clinically localized prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740331003662620

No effect of statins on biochemical outcomes after radiotherapy for localized prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740331003662620

Statin use and the risk of prostate cancer: A metaanalysis of 6 randomized clinical trials and 13 observational studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740331003662620

The influence of statin medications on prostate-specific antigen levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740331003662620

Cholesterol and cancer: answers and new questions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740331003662620

Prostate cancer and PSA among statin users in the Finnish prostate cancer screening trial.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2910322

Erratum: Screening statins for possible carcinogenic risk: up to 9 years of follow-up of 361 859 recipients

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2910322

Cerivastatin triggers tumor-specific apoptosis with higher efficacy than lovastatin.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2910322

Inhibition of epidermal growth factor-induced RhoA translocation and invasion of human pancreatic cancer cells by 3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibitors.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2910322

Lipid-Lowering Medication and Risk of Cancer

29 October 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740331003662620

Lipid-Lowering Drug Use and Breast Cancer in Older Women: A Prospective Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740331003662620

Long-Term Use of Statins and Risk of Colorectal Cancer: A Population-Based Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740331003662620

Following positive epidemiologic studies, statins to enter clinical trials for cancer prevention

21 January 2018

1 reference

12 December 2020

Cholesterol-lowering drugs and colorectal cancer incidence in a large United States cohort

1 reference

12 December 2020

Statins and breast cancer prevention: time for randomized controlled trials

1 reference

12 December 2020

Statins, especially atorvastatin, may improve survival following brachytherapy for clinically localized prostate cancer

1 reference

12 December 2020

Statins and cancer risk: a literature-based meta-analysis and meta-regression analysis of 35 randomized controlled trials

1 reference

12 December 2020

Statins and the risk of lung, breast, and colorectal cancer in the elderly

1 reference

12 December 2020

Statin Use and Risk of Colorectal Cancer

1 reference

12 December 2020

Adherence to Lipid-lowering Therapy and the Use of Preventive Health Services: An Investigation of the Healthy User Effect

1 reference

12 December 2020

Long-term follow-up of the West of Scotland Coronary Prevention Study

1 reference

12 December 2020

Cholesterol-lowering drugs and advanced prostate cancer incidence in a large U.S. cohort

1 reference

12 December 2020

3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors and the risk of cancer: a nested case-control study

1 reference

12 December 2020

Epidemiologic musing on statin drugs in the prevention of advanced prostate cancer

1 reference

12 December 2020

For patients with colorectal cancer, the long-term use of statins is associated with better clinical outcomes

1 reference

12 December 2020

Inhibition of lung tumor cell growth in vitro and mouse lung tumor formation by lovastatin

1 reference

12 December 2020

Statin use and the risk of breast cancer

1 reference

12 December 2020

The Risk of Cancer in Users of Statins

1 reference

12 December 2020

West of Scotland Coronary Prevention Study: identification of high-risk groups and comparison with other cardiovascular intervention trials

1 reference

12 December 2020

10.1517/14740331003662620

Identifiers

DOI

1 reference

30 July 2017

1 reference

30 July 2017

1 reference